Hello Finance Enthusiast!
We are back with another #EquityReport on Dr. Reddy’s Laboratories Ltd.
Dr. Reddy’s Laboratories Ltd., incorporated in the year 1984, is a Large Cap company operating in Pharmaceuticals sector. The company clocked 174.6 billion in revenue in the year ending 2020, which was 13% more than previous year. Their Profit after tax Rs. 19.5 billion , which increased by 4% YOY. North America Generics (NAG) is the largest market for the company, wherein FY2020, it contributed to around 47% of the company’s GG sales, and 37% of overall sales. The company has over 190 medications, 60 active pharmaceutical ingredients for drug manufacture, diagnostic kits, critical care, and biotechnology products. Revenue from India in FY2020 was 28.9 billion, presenting a growth of 11% compared to the previous year.